PathAI and Roche are partnering to develop and distribute PathAI's artificial intelligence (AI)-powered technology through Roche's uPath enterprise software.
The companies said the partnership allows for broad access to digital pathology diagnostics to support clinical research and companion diagnostic programs globally.
The collaboration will initially involve distributing algorithms developed by PathAI for research use only through Navify Digital Pathology, the cloud version of Roche's uPath enterprise software. The companies will focus on immuno-oncology in multiple cancer types.
The alliance will also support pharmaceutical partners with end-to-end software for companion diagnostic development using Roche's diagnostic assays and pathology lab solutions with imaging tools from PathAI in addition to the AI tools already provided by Roche.